Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who were diagnosed with cancer before the age of 21.
- People who are currently aged 5 years or older (this lower age limit exists because the measurement tools used in this trial have only been tested and proven reliable for this age group).
- People who were treated with certain chemotherapy drugs — specifically vinca alkaloids, platinum-based drugs, or other chemotherapy known to cause nerve damage.
- People who have been assessed by a trained physical therapist and found to have chemotherapy-related nerve damage, based on a specific scoring system (the ped-mTNS for those under 18 at the time of assessment, or the mTNS for those aged 18 or older at the time of assessment).
Who may not be able to join:
- People who are currently pregnant or breastfeeding, at the start of the trial or at any point during it.
- People who are unable to sit still for at least 15 minutes.
- People who had a nerve damage condition diagnosed before their cancer treatment began.
- People who currently have an active cancer diagnosis or a cancerous skin lesion.
- People who had a tumour in the brain or central nervous system (because the measurement tools used in this trial have not been validated for this group).
- People who have a cancer lesion, an open wound, or any other condition in the area to be treated that could potentially be made worse by the device used in this trial, whether used correctly or incorrectly.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rozalyn Rodwin, MD, Yale University
Phone: 203-785-2407
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of light therapy protocol
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.